← Back to Treatments
🏅 FDA Orphan Designation

Alkeran For Injection

Melphalan

Manufacturer: Glaxo Wellcome Inc.

Indicated for:
Steatocystoma multiplex-natal teeth syndromeOrphan
⚠️

Black Box Warning (Boxed Warning)

A Boxed Warning is the FDA's strongest safety warning — it indicates serious or life-threatening risks identified during clinical trials or post-market surveillance. It does not mean the medication is unsafe for all patients; your prescriber weighs these risks against the benefits for your specific situation. Source: FDA-approved prescribing information.

View full prescribing information on DailyMed (NLM) ↗

FDA-Approved Indications (1)

For the palliative treatment of patients with multiple myeloma for whom oral melphalan is not appropriate.

Indications & Usage

INDICATIONS AND USAGE Melphalan Hydrochloride for Injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate.

💙 Support Programs

View all →
Melphalan
Sagent
Alkeran For Injection
Glaxo Wellcome Inc.

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.